Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-25), Lerado Financial Group Co's Beta is 0.0957.
Lerado Financial Group Co (HKSE:01225) Beta Explanation
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Capital Markets subindustry, Lerado Financial Group Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lerado Financial Group Co Beta vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, Lerado Financial Group Co's Beta distribution charts can be found below:
* The bar in red indicates where Lerado Financial Group Co's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
Lerado Financial Group Co (HKSE:01225) has a Beta of 0.0957 as of Aug. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Lerado Financial Group Co and its competitors.
Is Lerado Financial Group Co's Beta too high?
Lerado Financial Group Co's current Beta is 0.0957. Overall, Lerado Financial Group Co has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lerado Financial Group Co's Beta compare to MS and GS?
Lerado Financial Group Co's Beta of 0.0957 can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Capital Markets company?
A good Beta depends on the Capital Markets industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Lerado Financial Group Co and its competitors. Lerado Financial Group Co's current Beta is 0.0957. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lerado Financial Group Co stock overvalued right now?
Based on GuruFocus' analysis, Lerado Financial Group Co (HKSE:01225) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.10, compared to a current price of HK$0.24 — trading 136% above its estimated fair value. The current Beta is 0.0957. Lerado Financial Group Co's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Lerado Financial Group Co (HKSE:01225), the current Beta is 0.0957 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lerado Financial Group Co (HKSE:01225) Overvalued in 2026?
Based on GuruFocus' analysis, Lerado Financial Group Co stock appears to be overvalued.
The current stock price of HK$0.24 is trading 136% above its estimated GF Value™ of HK$0.10.
GuruFocus considers Lerado Financial Group Co to be Significantly Overvalued.
Key valuation signals for HKSE:01225:
Beta: 0.0957
GF Value™: HK$0.10 vs. price of HK$0.24 (136% above fair value)
No single metric tells the full story. See the HKSE:01225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lerado Financial Group Co Ltd is an investment holding company. It is engaged in financial services, including securities broking, margin financing, and money lending, as well as manufacturing and distributing children's plastic toys and medical care products like mobility aids and other medical equipment. The group's operating segments are the Medical products and plastic toys business, Securities brokerage business and asset management services, and Money lending business and other financial services. It derives key revenue from the Medical products and plastic toys business segment, which involves the manufacturing and distribution of medical care products and plastic toys. It has a business presence in Hong Kong, Europe, the U.S., the PRC, Australia, South America, and other countries.
33GF Score
Get the complete analysis for HKSE:01225
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01225 has been successfully added to your 
